Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
VanEck High Yield Muni ETF
HYD
$4.42B
| $3.05M | ﹤0.01% |
48,800
-130,813
| -73% | -$8.14M |
|
2077
PUT
GameStop
GME
$8.55B
| $3.04M | ﹤0.01% |
82,000
-35,200
| -30% | -$1.6M |
|
2078
Astec Industries
ASTE
$1.21B
| $3.04M | ﹤0.01% |
43,896
+17,236
| +65% | +$1.08M |
|
2079
PUT
Emerson Electric
EMR
$86.7B
| $3.04M | ﹤0.01% |
32,700
-17,000
| -34% | -$1.6M |
|
2080
Graco
GGG
$13B
| $3.04M | ﹤0.01% |
37,682
-213,224
| -85% | -$16.2M |
|
2081
HSBC
HSBC
$370B
| $3.03M | ﹤0.01% |
100,586
+373
| +0.4% | +$10.9K |
|
|
VNET
2082
VNET Group
VNET
$2.04B
| $3.03M | ﹤0.01% |
335,569
+138,285
| +70% | +$1.88M |
|
2083
BioCryst Pharmaceuticals
BCRX
$2.24B
| $3.03M | ﹤0.01% |
218,532
+139,616
| +177% | +$1.85M |
|
2084
nVent Electric
NVT
$25.8B
| $3.03M | ﹤0.01% |
79,685
-34,682
| -30% | -$1.23M |
|
2085
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.16B
| $3.02M | ﹤0.01% |
136,225
+1,225
| +0.9% | +$27.6K |
|
2086
Under Armour Class C
UA
$2.83B
| $3.02M | ﹤0.01% |
167,587
-142,309
| -46% | -$2.76M |
|
2087
OFG Bancorp
OFG
$2.24B
| $3.02M | ﹤0.01% |
113,633
+34,535
| +44% | +$895K |
|
2088
National Bank Holdings
NBHC
$1.92B
| $3.01M | ﹤0.01% |
68,568
+18,520
| +37% | +$807K |
|
|
NSTG
2089
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.01M | ﹤0.01% |
71,257
+29,772
| +72% | +$1.3M |
|
2090
CALL
Guardant Health
GH
$21.3B
| $3M | ﹤0.01% |
30,000
| – | – |
|
2091
NBT Bancorp
NBTB
$2.75B
| $2.99M | ﹤0.01% |
77,657
+24,861
| +47% | +$928K |
|
2092
DXC Technology
DXC
$1.78B
| $2.98M | ﹤0.01% |
92,569
-8,431
| -8% | -$275K |
|
2093
AppFolio
APPF
$6.79B
| $2.98M | ﹤0.01% |
24,577
+15,970
| +186% | +$2.02M |
|
2094
Xencor
XNCR
$1.44B
| $2.97M | ﹤0.01% |
74,006
+22,151
| +43% | +$840K |
|
|
HMHC
2095
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $2.97M | ﹤0.01% |
184,516
+105,119
| +132% | +$1.6M |
|
2096
Marten Transport
MRTN
$1.22B
| $2.96M | ﹤0.01% |
172,769
+25,736
| +18% | +$426K |
|
2097
CoreCivic
CXW
$3B
| $2.96M | ﹤0.01% |
297,140
+53,759
| +22% | +$533K |
|
2098
S&T Bancorp
STBA
$1.85B
| $2.96M | ﹤0.01% |
93,888
+45,803
| +95% | +$1.42M |
|
2099
TAL Education Group
TAL
$6.7B
| $2.96M | ﹤0.01% |
752,455
+19,504
| +3% | +$88.1K |
|
2100
CryoPort
CYRX
$781M
| $2.95M | ﹤0.01% |
49,836
+33,260
| +201% | +$2.3M |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.